Vimarsana
Biggest News Aggregation in the World

Page 39 - Precaution Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precaution Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precaution Dose Today - Breaking & Trending Today

Many Indoreans waiting for new guidelines of precaution dose to travel abroad - Vimarsana News

Many Indoreans waiting for new guidelines of precaution dose to travel abroad

Large number of people reached health department in four days after Health Minister’s announcement of changing guidelines, officials waiting for changes in CoWin app

Norms for COVID-19 vaccination precaution dose relaxed for overseas travellers - Vimarsana News

Norms for COVID-19 vaccination precaution dose relaxed for overseas travellers

The Union Health Ministry's decision to relax the norms about the precaution dose for overseas travellers was based on recommendations by the National Technical Advisory Group on Immunisation (NTAGI).

India relaxes 9-month mandatory waiting period for Covid-19 precaution dose for overseas travellers | India News - Vimarsana News

India relaxes 9-month mandatory waiting period for Covid-19 precaution dose for overseas travellers | India News

Union Health Mansukh Mandaviya said in a tweet, “Indian citizens and students travelling overseas can now take the precaution dose as required by the guidelines of the destination country." 

Source: india.com
Covid-19: India relaxes 9-month gap for booster dose for foreign travellers - Vimarsana News

Covid-19: India relaxes 9-month gap for booster dose for foreign travellers

Covid-19 vaccine, precaution dose, Covid-19, Coronavirus, India, overseas travellers, Coronavirus vaccination, Covid vaccine, Vaccination, precaution dose, India booster dose, booster dose for travellers, india vaccine guidelines, india booster dose sops,COVID-19 vaccine, precaution dose, COVID-19,

Ground News - Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old - Vimarsana News

Ground News - Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

New Delhi:  Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population.